{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:50:31Z","timestamp":1783702231221,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jaad.2024.11.065","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T18:30:22Z","timestamp":1734719422000},"page":"930-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk of Candida and overall fungal infections with interleukin-17 inhibitors in the treatment of hidradenitis suppurativa: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"92","author":[{"given":"Miranda K.","family":"Branyiczky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohannad","family":"Abu-Hilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jaad.2024.11.065_bib1","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.3390\/ijms24098428","article-title":"New insight into the molecular pathomechanism and immunomodulatory treatments of hidradenitis suppurativa","volume":"24","author":"Molinelli","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10443","key":"10.1016\/j.jaad.2024.11.065_bib2","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials","volume":"403","author":"Kimball","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jaad.2024.11.065_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjd.15015","article-title":"Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management","volume":"177","author":"Saunte","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.11.065_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/pathogens8020054","article-title":"Interleukin-17 in antifungal immunity","volume":"8","author":"Sparber","year":"2019","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.jaad.2024.11.065_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40257-022-00686-z","article-title":"Candida infection associated with anti-IL-17 medication: a systematic analysis and review of the literature","volume":"23","author":"Yamanaka-Takaichi","year":"2022","journal-title":"Am J Clin Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224033838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224033838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:11:54Z","timestamp":1742357514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224033838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0190962224033838"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.11.065","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Candida and overall fungal infections with interleukin-17 inhibitors in the treatment of hidradenitis suppurativa: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.11.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}